Mengxian Sun

机构：Guangdong Pharmaceutical University, Key Laboratory of Guangdong Province, Integrated Chinese Medicine (China) · ORCID：0000-0003-0369-2148

发表论文 8 篇 · 总被引 95 次 · h-index 4

代表论文

• MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2 (2022 · Pharmacological Research · 被引 52)
• FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway (2022 · Biomedicine & Pharmacotherapy · 被引 18)
• The impact of YTHDF2-mediated NCOA4 methylation on myocardial ferroptosis (2025 · APOPTOSIS · 被引 9)
• Single-index composite quantile regression for ultra-high-dimensional data (2021 · Test · 被引 7)
• Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis (2022 · Evidence-based Complementary and Alternative Medicine · 被引 3)
• The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway (2022 · Evidence-based Complementary and Alternative Medicine · 被引 3)